Lorazepam Tablet
Product Images NDC 70518-0445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 70518-0445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Lorazepam 2 mg tablet label repackaged by RemedyRepack Inc. The label indicates it is a Schedule IV controlled substance with a quantity of 30 tablets. It includes the NDC number 70518-0445-00, manufacturer information, and cautions about storage temperature and proper use. The label also features a barcode and a QR code.*
FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Lorazepam Structure (Lorazepam Structure)
Chemical structure diagram of Lorazepam with molecular formula C15H10Cl2N2O2 and molecular weight 321.16.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.